Linda Crnic Institute for Down Syndrome Key Scientists
Tom Blumenthal, PhD
Executive Director, Linda Crnic Institute for Down Syndrome
Professor, Molecular, Cellular and Developmental Biology, University of Colorado
Tom Blumenthal’s lab studies the mechanisms of gene expression and how genes are organized on chromosomes. In 2010, he was named a fellow of the American Academy of Arts and Sciences, one of the nation’s most prestigious honorary societies. After earning a master’s degree at Antioch College, he earned his PhD from Johns Hopkins University. He came to the University of Colorado in 1987.
Joaquin Espinosa, PhD
Associate Director for Science, Linda Crnic Institute for Down Syndrome
Professor, Department of Pharmacology, University of Colorado
Dr. Joaquin Espinosa is the Associate Director for Science at the Linda Crnic Institute for Down Syndrome. He is also a Professor in the Department of Pharmacology at the University of Colorado Denver School of Medicine, the co-Leader of the Molecular Oncology program at the University of Colorado Cancer Center, and the founding Director of the Functional Genomics Facility at the University of Colorado.
Katheleen Gardiner, PhD
Professor, Department of Pediatrics, University of Colorado Denver
Linda Crnic Institute for Down Syndrome
Dr. Katheleen Gardiner moved to the University of Colorado in 2007 and joined the Linda Crnic Institute for Down Syndrome in 2012. Her current research focuses on protein expression in mouse and human model systems of Down syndrome. She has organized that last two international conferences on Down syndrome and the biology of human chromosome 21 in Washington DC.
Huntington Potter, PhD
Director of Alzheimer’s Research, Linda Crnic Institute for Down Syndrome and Department of Neurology, University of Colorado
Dr. Huntington Potter is Professor of Neurology and Director of Alzheimer’s Disease Research in the Department of Neurology and the Linda Crnic Center for Down Syndrome at the University of Colorado, Denver. He discovered and is devoted to studying the mechanistic relationship between Alzheimer’s Disease and Down syndrome. Recognizing that these disorders are two sides of the same coin and studying them together will best hasten the development of new treatments for both.